Bernoulli’s John Zaleski and Jeanne Venella co-author respiratory depression study in Biomedical Instrumentation & Technology
This report consists of two separate studies on the use of continuous capnography monitoring conducted in an effort to improve patient safety at Virtua Health System. The desire for improved patient safety is motivating continuous monitoring and improved surveillance in clinical areas not traditionally equipped for such monitoring. We explored the use of remote monitoring of capnography, using enterprise middleware, in patients recovering from surgery in a medical-surgical unit. Continuous monitoring traditionally has been used in higher-acuity settings, such as intensive care units. Patients diagnosed or suspected to have obstructive or central sleep apnea may benefit from the increased surveillance afforded by continuous monitoring. Pain management in this cohort of patients, recovering from bariatric, joint replacement, or other major surgery, often involves administration of opioids (e.g., hydromorphone, morphine sulfate), which are known to increase risk of respiratory depression. Continuous monitoring of these patients increases the likelihood of detecting adverse clinical events. Our goal was to implement continuous monitoring in order to identify alarm conditions caused by adverse clinical events requiring intervention (e.g., opioid-induced respiratory depression) and artifacts related to patient movement, suspect measurements, or other medical device–generated alarm signals.
John Zaleski featured in RT Magazine cover story on alarm management for respiratory therapists
John Zaleski, PhD, CAP, CPHIMS, Chief Analytics Officer of Bernoulli, the real-time leader in patient safety, is featured in the May/June cover story of RT Magazine, “Patient Monitoring and Alarm Fatigue.”
The article notes that alarm fatigue continues to remain a significant patient safety threat and details how clinicians can mitigate this problem.
Zaleski says that hospitals and health systems need better understanding of their current state environment, including clinical workflows, patient cohorts, and assessments in order to develop comprehensive guidelines and protocols for clinical alarm management.
As for solutions, Zaleski recommends one with integration capabilities. “Combinatorial alarms take multiple sources of information and bring it together to corroborate events. This is not simply limited to data extracted in real time from patient care devices at the point of care, but also can be drawn from ancillary sources.”
Read the cover story here. A case study on Bernoulli’s success in ventilator alarm management at the Hospital for Special Care is available here.
Be sure to also follow Bernoulli on LinkedIn and Twitter for the latest news and updates.
Bernoulli will be exhibiting at the AAMI Conference and Expo booth #1226
Bernoulli will be exhibiting at the AAMI Conference and Expo.
Bernoulli will be exhibiting at the AAMI Conference and Expo. The conference is in Austin, Texas from June 9th to 12th; Bernoulli will be in booth # 1226.
The conference has long been well known as the place where innovation, connection, and advancement in medical technologies come together. It is where the very best and the very brightest join together to exchange ideas on better performance, service, improved patient safety, and better quality of life in the medical industry.
At the AAMI Conference and Expo Bernoulli One™ the company’s flagship platform will show that better results in allocation of personnel resources at reduced support costs is not only a possibility but also a reality.
Bernoulli One™ is a connected, end to end, powerful and predictive capability in analytics, robust distribution, advanced alarm management, clinical surveillance and more, all in one solution.
About Bernoulli
Bernoulli is the industry’s premier leader in real time, real life, patient care monitoring systems and data. That is because the people at Bernoulli intuitively know that a patient’s care, their safety and well being, and their continued health is their most important priority. Their efforts in dynamically programmable intelligent appliances for control, connectivity, monitoring and management reflect that.
Friendly service, professional advice, and direct answers will be on hand at the conference to help provide the solutions to improving patient safer in in real time. For more information on how we can help you please follow the link Bernoullihealth.com
For additional information on the conference go to: http://www.aami.org/annualconference/
Bernoulli case study details multi-hospital medical device connectivity
Bernoulli, the real-time leader in patient safety, has published a new case study detailing its successful efforts to bring medical device integration to Virtua, one of New Jersey’s largest non-profit, multi-hospital health systems.
Utilizing Bernoulli’s standards-based, open architecture Bernoulli One™ system enabled Virtua to bring medical device integration and connectivity across a complex healthcare ecosystem with an integrated, scalable, secure, and cost-effective web-based platform.
Virtua’s need for medical device integration and connectivity grew in part to free clinicians from writing out hundreds of patient data numbers from scores of different devices and machines every day in the course of care delivery. The health system wanted a plug-and-play medical connectivity paradigm that was uniform across different departments, could seamlessly interface with their Epic EHR, and could easily scale with the health system’s future growth.
With the conclusion of the Phase I integration in Virtua’s Perioperative Department, which includes Endoscopy, ECT and Interventional Radiology, the health system has realized complete electronic documentation, which has allowed clinicians to devote more of their time facing the patient and meeting their care needs.
Phase II will focus on Virtua’s Critical Care Unit, which includes the ICU and NICU/PICU, and will integrate the units’ physiological monitors, ventilators, anesthesia machines, smart tourniquets, and brain activity monitors.
Bernoulli One™, the company’s flagship platform, is the market’s only real-time, end-to-end, connected healthcare platform that combines comprehensive and vendor-agnostic medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into one solution.
Bernoulli’s vectored event grid architecture enables true interoperability across disparate devices, networks, and systems by utilizing dynamically programmable intelligent appliances at the network edge. The system’s granular level of patient data detail, in real-time, at the point of care for improved decision support applications while also providing flexibility for user-defined configuration and control for device connectivity, monitoring and management, results in better allocation of personnel resources and reduced support costs.
Read the case study here and learn more about Bernoulli’s medical device integration and connectivity solutions here.
Be sure to also follow Bernoulli on LinkedIn and Twitter for the latest news and updates.
Bernoulli to Exhibit at 19th Annual NPSF Patient Safety Congress
Bernoulli, the leader in real-time solutions for patient safety, will be exhibiting at Booth 715 at the 19th Annual NPSF Patient Safety Congress, May 17-19, 2017, at the Renaissance Orlando at SeaWorld hotel, Orlando, FL.
Bernoulli will be highlighting its capabilities in real-time data, medical device integration and patient safety solutions, as well as its latest application for the continuous monitoring of patients at risk of respiratory depression—Respiratory Depression Safety Surveillance (RDSS).
“Analysts have stressed the importance of hospitals providing the right information, at the right time, in the right format and to the right clinicians to enable real-time patient safety initiatives,” said Bernoulli CEO Janet Dillione. “The NPSF Congress us to engage with IT leaders on the frontlines, hear how they are approaching and adapting to healthcare’s rapidly changing landscape, and learn the real costs and considerations they face in finding a solution to their hospital’s unique challenges.”
RDSS utilizes comprehensive real-time data to help clinicians quickly recognize and respond to signs of respiratory distress. RDSS includes exclusive analytics with multi-variable thresholds—adjustable by the care facility—to identify clinically actionable events while significantly reducing the overall number of alarms communicated to remote and mobile clinicians, mitigating the risk of alarm fatigue.
The platform provides connectivity to a hospital’s existing fleet of pulse oximeters and capnographs from a wide range of vendors, including Medtronic, Masimo and others. RDSS also integrates with mobile clinical communication tools to deliver the right alarms and alerts to the right caregiver at the right time.
A forthcoming clinical study of patients diagnosed or at risk of obstructive or central sleep apnea, to be published in the Journal of Biomedical Instrumentation & Technology, the use of Bernoulli’s RDSS analytics reduced 22,812 alarms generated by bedside capnographs and pulse oximeters to just 209 respiratory depression alerts delivered to mobile clinicians—a reduction of 99%. More importantly, the RDSS analytics distributed alerts for every patient that experienced an actual respiratory depression episode.
Follow Bernoulli on LinkedIn and Twitter for additional updates, as well as access to case studies, thought leadership and other information.
Janet Dillione named one of Medtech’s Women to know
Bernoulli’s CEO, Janet Dillione, one of Medtech ‘s Women to Know in 2017.
Janet Dillione, CEO of Bernoulli named one of Becker’s Hospital Review’s “ Medtech Women to Know”. This is a prestigious recognition honoring select women in the healthcare field industry. This is a prestigious recognition honoring select women in the healthcare field industry. This dynamic group of 110 women executives are sharing ideas and shaping the future of healthcare IT, Medical Devices and Technology with real-life solutions to the most challenging issues facing the healthcare industry today.
According to a 2012 Forbes article, only 4% of healthcare CEOs are women yet female led companies are leading the change in healthcare field. Perhaps it is because women traditionally make more than 80% of healthcare decisions.
Janet Dillione’s professional life is dedicated to the healthcare industry.
She has been at the helm at making significant cutting edge changes that have resulted in positive impacts to healthcare in general. Her many awards include “17 Female Health IT Company CEOs to Know” , “Top 25 Women in Healthcare”, and “One of the Most Powerful Women in the Technology”. These articles reinforce Janet Dillione as a recognized inspiration to women in the industry.
Ms. Dillione’s passion for improving healthcare and her drive for excellence has been repeatedly demonstrated throughout her successful 25 year career in Health Services.
Ms. Dillione supports efforts to improve the quality and safety of healthcare delivery and technology’s role. Proof can be seen in her drive for patient safety. She continuously puts Bernoulli front and center in its focus on the real-time connected healthcare platform that combines comprehensive and vendor agnostic medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities.
Their Bernoulli One™ platform empowers clinicians with the tools like medical device integration, alarm management, virtual ICU, clinical surveillance, and analytics as a total solution that improves the patient experience and patient safety.
You find out more about the Bernoulli One™ platform go to http://bernoullihealth.com/
To see the entire list of 110 women go to http://www.beckershospitalreview.com/lists/110-women-in-medtech-to-know-2017.html
Janet Dillione named one of Medtech Women to know
Bernoulli’s CEO, Janet Dillione, one of Medtech ‘s Women to Know in 2017.
Janet Dillione, CEO of Bernoulli named one of Becker’s Hospital Review’s “Medtech Women to Know”. This is a prestigious recognition honoring select women in the healthcare field industry. This dynamic group of 110 women executives are sharing ideas and shaping the future of healthcare IT, Medical Devices and Technology with real-life solutions to the most challenging issues facing the healthcare industry today.
According to a 2012 Forbes article, only 4% of healthcare CEOs are women yet female led companies are leading the change in healthcare field. Perhaps it is because women traditionally make more than 80% of healthcare decisions.
Janet Dillione’s professional life is dedicated to the healthcare industry.
She has been at the helm at making significant cutting edge changes that have resulted in positive impacts to healthcare in general. Her many awards include “17 Female Health IT Company CEOs to Know” , “Top 25 Women in Healthcare”, and “One of the Most Powerful Women in the Technology”. These articles reinforce Janet Dillione as a recognized inspiration to women in the industry.
Ms. Dillione’s passion for improving healthcare and her drive for excellence has been repeatedly demonstrated throughout her successful 25 year career in Health Services.
Ms. Dillione supports efforts to improve the quality and safety of healthcare delivery and technology’s role. Proof can be seen in her drive for patient safety. She continuously puts Bernoulli front and center in its focus on the real-time connected healthcare platform that combines comprehensive and vendor agnostic medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities.
Their Bernoulli One platform empowers clinicians with the tools like medical device integration, alarm management, virtual ICU, clinical surveillance, and analytics as a total solution that improves the patient experience and patient safety.
You find out more about the Bernoulli One platform go to Bernoulli One platform page
To see the entire list of 110 women go to http://www.beckershospitalreview.com/lists/110-women-in-medtech-to-know-2017.html
Bernoulli Launches Respiratory Depression Safety Surveillance ( RDSS ) Solution
Revolutionary New Analytics Application to Address Significant Patient Safety Threat
Milford, CT—April 3, 2017—Bernoulli, the leader in real-time solutions for patient safety, has announced a revolutionary new application for the continuous monitoring of patients at risk of respiratory depression. Bernoulli’s Respiratory Depression Safety Surveillance (RDSS) solution utilizes comprehensive real-time data to help clinicians quickly recognize and respond to signs of respiratory distress. RDSS includes exclusive analytics with multi-variable thresholds—adjustable by the care facility—to identify clinically actionable events while significantly reducing the overall number of alarms communicated to remote and mobile clinicians, mitigating the risk of alarm fatigue.
A Solution to a Growing Patient Safety Threat
More than half of medication-related deaths and 20,000 incidences of respiratory depression-related interventions annually are attributed to the delivery of opioids in a care setting, at a cost of approximately $2 billion per year to the U.S. healthcare system.1
Current monitoring practices are neither adequate nor comprehensive. For example, one of the most common methods—periodic physical spot checks by direct-care clinical staff—can leave patients unmonitored up to 96% of the time.2 Additionally, the adoption of continuous respiratory surveillance is beset by significant challenges, including reduced visual and audible oversight due to single-patient rooms and high nurse-to-patient ratios in many care areas with at-risk patients, and limitations of stand-alone respiratory monitoring devices that can have high rates of false and non-clinically actionable alarms. The disruption of direct-care clinical staff workflow also is a major barrier to continuous monitoring.
Bernoulli’s RDSS solution mitigates many of these clinical, technical and operational challenges. The platform provides connectivity to a hospital’s existing fleet of pulse oximeters and capnographs from a wide range of vendors, including Medtronic, Masimo and others. RDSS also integrates with mobile clinical communication tools to deliver the right alarms and alerts to the right caregiver at the right time.
Proven Clinical Results
In a forthcoming clinical study of patients diagnosed or at risk of obstructive or central sleep apnea, to be published in the Journal of Biomedical Instrumentation & Technology3, the use of Bernoulli’s RDSS analytics reduced 22,812 alarms generated by bedside capnographs and pulse oximeters to just 209 respiratory depression alerts delivered to mobile clinicians—a reduction of 99%. More importantly, the RDSS analytics distributed alerts for every patient that experienced an actual respiratory depression episode.
“The risks inherent in delivering opioids or patient-controlled analgesia to post-operative patients increase the possibility for sentinel events, particularly in patient populations managing chronic illnesses or co-morbidities, such as sleep apnea and obesity,” said Janet Dillione, CEO of Bernoulli. “Bernoulli’s RDSS solution effectively delivers on the recommendations of The Joint Commission, AAMI Foundation and ECRI Institute that hospitals implement continuous respiratory monitoring for these at-risk patients.”
References
- Overdyk FJ, Carter R, Maddox RR, Callura J, Herrin AE, Henriquez C. Continuous Oximetry / Capnometry Monitoring Reveals Frequent Desaturation and Bradypnea During Patient-Controlled Analgesia. Anesth Analg. 2007;105:412-8.
- Wong M, Mabuyi A, Gonzalez B. First National Survey of Patient-Controlled Analgesia Practices. Physician-Patient Alliance for Health & Safety (PPAHS), October 2013; Web page: premiersafetyinstitute.org/wp-content/uploads/PPAHS-national-survey-patient-controlled-analgesia.pdf.
- Supe D, Baron L, Decker T, Parker K, Venella J, Williams S, Beaton K, Zaleski J. A pilot study in middleware-filtered capnography alarms of continuously monitored obstructive sleep apnea patient in a medical-surgical unit. BI&T. May/June 2017. Manuscript in preparation.
About Bernoulli
Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli One™, visit www.bernoullihealth.com. Follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.
Accolades
